US Stock MarketDetailed Quotes

ALXO ALX Oncology

Watchlist
  • 1.515
  • -0.115-7.06%
Close Jan 24 16:00 ET
  • 1.490
  • -0.025-1.65%
Post 20:01 ET
79.91MMarket Cap-0.51P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    72839823
    72839823
    Yesterday 01:09
    $ALX Oncology (ALXO.US)$ , Why Jeffries cut it’s rating saying it did not meet the expectation?  The report seems to be better than what Jeffries said.
    3
    Trytosaveabit
    Trytosaveabit
    Jan 23 07:07
    news
    $ALX Oncology (ALXO.US)$ ALX Oncology Presents Positive Updated Data From ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients With HER2-Positive Gastric Cancer
    GlobeNewswire· 6 mins ago
    Jaguar8
    Jaguar8
    Jan 23 07:01
    NEWS
    $ALX Oncology (ALXO.US)$
    ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer
    Thursday, 23rd January at 8:00 am
    • Oral presentation at 2025 ASCO Gastrointestinal Cancers Symposium today highlights evorpacept as the first CD47 blocker to show substantial tumor response and a well-tolerated safety profile in a prospective randomized trial
    • Greatest ...
    Jaguar8
    Jaguar8
    Jan 21 16:10
    NEWS
    $ALX Oncology (ALXO.US)$
    ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI
    Tuesday, 21st January at 5:00 pm
    • Webcast on January 23 at 1:00 p.m. PT/4:00 p.m. ET will review updated data from trial evaluating CD47-blocker evorpacept in HER2-positive gastric cancer
    SOUTH SAN FRANCISCO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (NASDAQ: ALXO), a clinical-stage ...
    Jaguar8
    Jaguar8
    Dec 10, 2024 08:02
    NEWS
    $ALX Oncology (ALXO.US)$
    ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with Zanidatamab Generates Promising Antitumor Activity in Advanced Breast Cancer
    Tuesday, 10th December at 9:00 am
    Data from Phase 1b/2 clinical trial to be presented at 2024 San Antonio Breast Cancer Symposium (SABCS) show encouraging clinical activity in patients with heavily pretreated HER2-positive breast cancer who had received multiple HER2-targeted agents, including fam-trastuzumab deruxt...
Read more

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
GVS
870976
+29.98%
Hangzhou CNCR-IT
300250
+20.03%
Shanghai Newtouch Software
688590
+20.01%
4
Ucap Cloud Information Technology Co.,Ltd
688228
+20.00%
5
Yangtze Optical Electronic
688143
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks Show More
Ask a strategist - Trump's first day
Earnings Season Underway
Earnings season is here. What to know?